Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05739565
Other study ID # 20PH286
Secondary ID 2022-A01094-39
Status Recruiting
Phase N/A
First received
Last updated
Start date April 25, 2023
Est. completion date September 30, 2026

Study information

Verified date June 2023
Source Centre Hospitalier Universitaire de Saint Etienne
Contact HUPIN DAVID, MD
Phone (0)477828413
Email David.Hupin@chu-st-etienne.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Despite the recognized benefits of physical activity in tertiary prevention, 60-70% of prostate cancer patients are insufficiently active. Yet 150 minutes of brisk walking per week (new WHO recommendations) is associated with a 29% reduction in cancer mortality and a 57% reduction in recurrence. Increasing patients' adherence to regular physical activity appears to be a new challenge for personalized cancer care. Personalized physical activity programmes (1) at home, (2) supported by health professionals, or (3) by peers have shown the effectiveness of regular physical activity. However, these interventions last less than 6 months and do not allow for long-term sustainability of physical activity. This study proposes to combine 3 interventions, which aim to initiate and maintain regular physical activity in prostate cancer patients: - 1-The realization of a personalized and realistic physical activity project via physical activity support devices (sport health centers) - 2-Coaching by a peer (a patient with the same disease who has reached the WHO recommendations for physical activity), who will provide motivational follow-up - 3-Support by health professionals (attending physician) through the prescription of physical activity. The feasibility of ACTI-PAIR program has been demonstrated, the investigators now wish to evaluate it effectiveness.


Recruitment information / eligibility

Status Recruiting
Enrollment 850
Est. completion date September 30, 2026
Est. primary completion date September 30, 2025
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: Patients: - Age = 18 years - Diagnosed with prostate cancer for at least 1 year - PA practice < 150 minutes per week (considered inactive according to WHO) - Affiliated or entitled to a social security scheme - Having received informed information about the study and having co-signed, with the investigator, a consent to participate in the study Exclusion Criteria: For patients: - Undergoing treatment (except hormone therapy) - Significant comorbidities contraindicating the practice of physical activity: associated cardiac pathologies, respiratory pathologies, disabling joint pathologies - Deprived of liberty or under guardianship

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Acti-Pair program
Motivational support by the peer (a patient with the same pathology who meets the WHO recommendations for physical activity), who will provide motivational follow-up The implementation of a personalized and realistic physical activity project for the patient via the physical activity support systems (sport health centers) Support from health professionals (GP) via the prescription of physical activity and from adapted physical activity (APA) professionals

Locations

Country Name City State
France Activité Physique Adaptée - CDOS Savoie Chambéry
France CH Chambéry Chambéry
France Activité Physique Adaptée - DAHLIR 63 Clermont-Ferrand
France CHU Clermont-Ferrand - ONCOLOGIE Clermont-Ferrand
France CHU Clermont-Ferrand - Urologie Clermont-Ferrand
France Activité Physique Adaptée - CDOS Isère Grenoble
France CHU Grenoble - Urologie Grenoble
France Activité Physique Adaptée - DAHLIR 43 Le Puy-en-Velay
France CH Le Puy en Velay Le Puy-en-Velay
France Activité Physique Adaptée - DAHLIR 69 Lyon
France CLB - Oncologie Lyon
France CLB - Radiothérapie Lyon
France HCL - CH Lyon Sud Lyon
France HCL - Hôpital Croix Rousse Lyon
France HCL - Hôpital Edouard Herriot Lyon
France Activité Physique Adaptée - CDOS Ardèche Privas
France CH Roanne Roanne
France Activité Physique Adaptée - DAPAP 42 Saint-Étienne
France CHU Saint-Etienne - Oncologie Saint-Étienne
France CHU Saint-Etienne - Radiothérapie Saint-Étienne
France Hôpital Privé de la Loire Saint-Étienne
France Clinique du parc Saint-Priest-en-Jarez
France Activité Physique Adaptée - CDOS Drôme Valence
France Hôpitaux Drôme Nord - Valence Valence
France Radiologie Drôme-Ardèche - Valence Valence

Sponsors (6)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Saint Etienne INSERM ECEVE 1123, INSERM, CIC1408, INSERM, SAINBIOSE U1059, Ministry of Health, France, Sport Health Center of Auvergne-Rhône Alpes

Country where clinical trial is conducted

France, 

References & Publications (11)

Baudot A, Barth N, Colas C, Garros M, Garcin A, Oriol M, Roche F, Chauvin F, Mottet N, Hupin D; on behalf the Acti-Pair investigators. The physical activity experience of prostate cancer patients: a multicentre peer motivation monitoring feasibility study. The Acti-Pair study. Pilot Feasibility Stud. 2022 Jan 21;8(1):12. doi: 10.1186/s40814-022-00966-9. — View Citation

Blaney JM, Lowe-Strong A, Rankin-Watt J, Campbell A, Gracey JH. Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey. Psychooncology. 2013 Jan;22(1):186-94. doi: 10.1002/pon.2072. Epub 2011 Oct 6. — View Citation

Bonn SE, Sjolander A, Lagerros YT, Wiklund F, Stattin P, Holmberg E, Gronberg H, Balter K. Physical activity and survival among men diagnosed with prostate cancer. Cancer Epidemiol Biomarkers Prev. 2015 Jan;24(1):57-64. doi: 10.1158/1055-9965.EPI-14-0707. Epub 2014 Dec 19. — View Citation

Buman MP, Giacobbi PR Jr, Dzierzewski JM, Morgan AA, McCrae CS, Roberts BL, Marsiske M. Peer Volunteers Improve Long-Term Maintenance of Physical Activity With Older Adults: A Randomized Controlled Trial. J Phys Act Health. 2011 Sep;8(s2):S257-S266. doi: 10.1123/jpah.8.s2.s257. — View Citation

Galvao DA, Newton RU, Girgis A, Lepore SJ, Stiller A, Mihalopoulos C, Gardiner RA, Taaffe DR, Occhipinti S, Chambers SK. Randomized controlled trial of a peer led multimodal intervention for men with prostate cancer to increase exercise participation. Psychooncology. 2018 Jan;27(1):199-207. doi: 10.1002/pon.4495. Epub 2017 Jul 27. — View Citation

Livingston PM, Craike MJ, Salmon J, Courneya KS, Gaskin CJ, Fraser SF, Mohebbi M, Broadbent S, Botti M, Kent B; ENGAGE Uro-Oncology Clinicians' Group. Effects of a clinician referral and exercise program for men who have completed active treatment for prostate cancer: A multicenter cluster randomized controlled trial (ENGAGE). Cancer. 2015 Aug 1;121(15):2646-54. doi: 10.1002/cncr.29385. Epub 2015 Apr 15. — View Citation

Phillips SM, Stampfer MJ, Chan JM, Giovannucci EL, Kenfield SA. Physical activity, sedentary behavior, and health-related quality of life in prostate cancer survivors in the health professionals follow-up study. J Cancer Surviv. 2015 Sep;9(3):500-11. doi: 10.1007/s11764-015-0426-2. Epub 2015 Apr 16. — View Citation

Pinto BM, Stein K, Dunsiger S. Peers promoting physical activity among breast cancer survivors: A randomized controlled trial. Health Psychol. 2015 May;34(5):463-72. doi: 10.1037/hea0000120. Epub 2014 Aug 11. — View Citation

Richman EL, Kenfield SA, Stampfer MJ, Paciorek A, Carroll PR, Chan JM. Physical activity after diagnosis and risk of prostate cancer progression: data from the cancer of the prostate strategic urologic research endeavor. Cancer Res. 2011 Jun 1;71(11):3889-95. doi: 10.1158/0008-5472.CAN-10-3932. Epub 2011 May 24. — View Citation

Steindorf K, Depenbusch J, Haussmann A, Tsiouris A, Schmidt L, Hermann S, Sieverding M, Wiskemann J, Ungar N. Change patterns and determinants of physical activity differ between breast, prostate, and colorectal cancer patients. Support Care Cancer. 2020 Jul;28(7):3207-3218. doi: 10.1007/s00520-019-05097-1. Epub 2019 Nov 13. — View Citation

Tudor-Locke C, Lauzon N, Myers AM, Bell RC, Chan CB, McCargar L, Speechley M, Rodger NW. Effectiveness of the First step Program delivered by professionals versus peers. J Phys Act Health. 2009 Jul;6(4):456-62. doi: 10.1123/jpah.6.4.456. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Objective measurement of physical activity (in MET-hr/week, Metabolic Equivalent of Task (MET), measures the intensity of physical activity) via actimetry (Actigraph GT9x, Pensacola, Florida, USA) 12 months (+/- 1 month) after the patient's inclusion in the Acti-Pair program Month: 12
Secondary Objective measurement of physical activity (in MET-hr/week, Metabolic Equivalent of Task (MET), measures intensity of physical activity) via actimetry (Actigraph GT9x, Pensacola, Florida, USA) (at 3 and 6 months). Inclusion, 3, 6 and 12 months
Secondary Objective measure of physical inactivity (in h/d) via actimetry (Actigraph GT9x, Pensacola, Florida, USA) Inclusion, 3, 6 and 12 months
Secondary Subjective measurement of physical activity (in Metabolic equivalent of task-h/week) and sedentary time (h/d) Via the e-Adult Physical Activity Questionnaire (e-APAQ, EA SNA-EPIS, University of Jean Monnet, Saint-Etienne, France) e-Adult Physical Activity Questionnaire (e-APAQ) assesses the 5 categories of physical activity (work, travel, daily life, leisure and sport) and daily life, leisure and sport). The minimum value is 1 and the maximum value is 300. More the physical activity score is high, more the patient is active. This questionnaire authenticates the periods of sedentarity (at work, during travel and daily life, leisure and sport). The minimum value is 1 and the maximum value is 24. More the sedentarity score is high, more the patient is sedentary. Inclusion, 3, 6 and 12 months
Secondary Measurement of physical capacity: walking distance (meters) via the 6-minute walk test (6MWT). Inclusion, 3, 6 and 12 months
Secondary Measurement of muscle strength: biceps muscle strength (kg) via the handgrip (JAMAR Hand Dynamometer, Nottingham, UK). Inclusion, 3, 6 and 12 months
Secondary Level of fatigue assessed by measuring heart rate variability (SDNN and RMSSD in ms) via heart rate monitor connected to an actimeter (Actigraph GT3x, Pensacola, Florida, USA) for 24 hours Inclusion, 3, 6 and 12 months
Secondary Level of fatigue via the FACIT-F questionnaire (Functional Assessment of Chronic Illness Therapy - Fatigue Scale). This questionnaire asseses fatigue and it impacts. The score range is 0 to 160. More the score is higher, more the fatigue is high. Inclusion, 3, 6 and 12 months
Secondary Health-related quality of life via the EuroQol-5D questionnaire (EQ-5D-5L). The score range is -0.148 to 0.949. Mre the score is high, more the quality of life is good. Inclusion, 3, 6 and 12 months
Secondary Adoption of Acti-Pair program by physicians Number of physicians including patients through end of inclusion, an average of 30 months
Secondary Adoption of Acti-Pair program by peers Number of peers recruited through end of inclusion, an average of 30 months
Secondary Adoption of Acti-Pair program by Adapted Physical Activity (APA) professionals Number of patients followed by APA professionals through study completion, an average of 42 Months
Secondary Time dedicated by peers, Adapted Physical Activity (APA) professionals and health professionals to the Acti-Pair program Number of hours spend to follow-up patient specifically for the Acti-Pair program by peers, Adapted Physical Activity (APA) professionals and health professionals through study completion, an average of 42 Months
Secondary Assessment of the context:factors favoring and hindering implementation, achievement, adaptation and sustainability of the programme ; compliance with the programme ; social representations Semi-structured interviews Before and after the implementation of the intervention
Secondary Percentage of adherence to the intervention via the number of patients continuing the programme 12 months after initiation 12 months
Secondary Motivation to engage in physical activity for patients and peers via the behavioural regulation in exercise questionnaire (BREQ-2). This questionnaire consists of 19 items includes 6 sub-scores of motivations : introjected regulation (3 items), external regulation (4 items), intrinsic regulation (4 items), integrated regulation, amotivation (4 items) and identified regulation (4 items) on a scale from 1 (Not at all true for me) to 5 (Absolutely true for me). Inclusion, 3, 6 and 12 months
Secondary Alliance between the patient and the peer via the Working Alliance Inventory - short version (WAI-SR). This questionnaire measures three dimensions: bonding (development of a positive interpersonal attachment between the patient and the peer including mutual trust and respect), tasks (each partner's perception of the appropriateness and effectiveness of the care tasks, as well as tasks, as well as shared responsibility for their execution) and goals (understanding, validation and acceptance by both partners of the objectives of change in physical activity management).
Patients rate items on a 5-point Likert scale anchored at each end with 'rarely or never' (1) and 'always' (5). The Goal, Task and Bond domains each have scores ranging from 5 to 20. Higher scores indicate a better therapeutic alliance.
12 months
Secondary Patients, peers and professionals satisfaction Via a satisfaction questionnaire constructed for the Acti-Pair programme. The proposed responses are a likert scale ranging from Strongly Agree to Strongly Disagree. Each item will be described with a percentage of Likert scale for each response. More participants will fill out they have been strongly agree, more they will be satisfied.This questionnaire does not have a score. 12 months
Secondary Cost per quality adjusted life year (QALY) gained through the intervention (quality adjusted life year) Quality of life data will be collected (e.g. quality of life using the EQ-5D-5L questionnaire, Appendix 3), transformed into utilities to calculate quality adjusted life year (QALY), and the number of patients continuing physical activity at 12 months. Cost data will be collected throughout the study, in each of the 8 departments involved. The analysis will be carried out from the payer's (health insurance) perspective. The time horizon will be that of the study (12 months), and therefore in accordance with French guidelines (HAS), no discount rate will be applied 12 months
Secondary Cost per patient continuing physical activity at 12 months through the intervention The costs will include : - direct medical costs : health professionals consultations, peer-to-peer, patient sessions with APA professionals - indirect costs of implementing the intervention: training, facility rental operating costs, investment in small equipment 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05613023 - A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT Phase 3
Recruiting NCT05540392 - An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues Phase 1/Phase 2
Recruiting NCT05156424 - A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer Phase 1/Phase 2
Completed NCT03177759 - Living With Prostate Cancer (LPC)
Completed NCT01331083 - A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer Phase 2
Recruiting NCT05540782 - A Study of Cognitive Health in Survivors of Prostate Cancer
Active, not recruiting NCT04742361 - Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer Phase 3
Completed NCT04400656 - PROState Pathway Embedded Comparative Trial
Completed NCT02282644 - Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry N/A
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT06305832 - Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer Phase 2
Recruiting NCT05761093 - Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
Completed NCT04838626 - Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection Phase 2/Phase 3
Recruiting NCT03101176 - Multiparametric Ultrasound Imaging in Prostate Cancer N/A
Completed NCT03290417 - Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer N/A
Completed NCT00341939 - Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed NCT01497925 - Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer Phase 1
Recruiting NCT03679819 - Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
Completed NCT03554317 - COMbination of Bipolar Androgen Therapy and Nivolumab Phase 2
Completed NCT03271502 - Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy N/A